Gatifloxacin Ophthalmic

283 interactions 389 cited references

Also sold as: Zymar® Zymaxid Zymaxid®

About Gatifloxacin Ophthalmic

Gatifloxacin ophthalmic solution is used to treat bacterial conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids) in adults and children 1 year of age and older. Gatifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the… Read the full Gatifloxacin Ophthalmic drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dronedarone Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir

12 Contraindicated 254 Major 17 Moderate

All (283) Contraindicated (12) Major (254) Moderate (17)

Contraindicated

Gatifloxacin Ophthalmic Bepridil An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Cisapride Propulsid® Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Dronedarone Multaq Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Levoketoconazole Recorlev An increased risk of QT interval prolongation and an increased risk of torsade de pointes Details Gatifloxacin Ophthalmic Mesoridazine An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Pimozide An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Piperaquine An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Saquinavir An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Sparfloxacin An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Terfenadine An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Thioridazine An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Ziprasidone Geodon An increased risk of QT interval prolongation Details

Major

Gatifloxacin Ophthalmic Acarbose Prandase® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Acecainide An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Acetophenazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Adagrasib Krazati An increased risk of QT interval prolongation, torsade de pointes, polymorphic ventricular tachycardia, other serious arrhythmias Details Gatifloxacin Ophthalmic Albiglutide Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Alfuzosin UroXatral An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Alogliptin Nesina Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Alosetron Increased plasma concentration and half-life of alosetron Details Gatifloxacin Ophthalmic Amiodarone Nexterone An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Amisulpride Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Gatifloxacin Ophthalmic Amitriptyline Elavil An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Amoxapine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Anagrelide Agrylin Increased anagrelide exposure and increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Apomorphine Apokyn An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Aripiprazole Abilify An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Aripiprazole Lauroxil Aristada An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Artemether An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Asenapine Saphris Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Astemizole An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Atazanavir Reyataz An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Azimilide An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Azithromycin AzaSite An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Bedaquiline Sirturo Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Betamethasone Betavet An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Bretylium An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Budesonide Entocort An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Buprenorphine Belbuca An increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.